Disclosure 0001193125-26-396894-1

SEC FORM 4

$5,347.76

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 1,417 shares at $3.7740 per share.

Reporting Person Yonehiro Grant · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 21, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001193125-26-396894 · filed 2026-09-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Bolt Biotherapeutics, Inc. (BOLT)." Disclosed 2026-09-21. https://desqlong.com/cards/0001193125-26-396894-1 (retrieved 2026-09-26).